AtriCure, Inc.

ATRC ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $54.5M
Cost of Revenue $12.8M
Gross Profit $41.8M
Gross Margin 76.6%
Operating Expenses
Research & Development $11.4M
SG&A Expense $35.1M
Operating Income $-15.5M
Operating Margin -28.4%
Interest Expense $812.3K
Pretax Income $-16.6M
Income Tax Expense $-58.6K
Net Income $-16.5M
Net Margin -30.2%
EPS (Basic) $-1.13
EPS (Diluted) $-1.13
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share
← Newer Page 3 of 3 Older →